Board Meeting

ALEMBIC PHARMACEUTICALS LTD.

NSE : APLLTDBSE : 533573ISIN CODE : INE901L01018Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE982.35-1.5 (-0.15 %)
PREV CLOSE ( ) 983.85
OPEN PRICE ( ) 1003.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4654
TODAY'S LOW / HIGH ( )968.60 1003.05
52 WK LOW / HIGH ( )463.3 1093.05
NSE984.800.05 (+0.01 %)
PREV CLOSE( ) 984.75
OPEN PRICE ( ) 994.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 984.80 (16)
VOLUME 141639
TODAY'S LOW / HIGH( ) 969.60 997.35
52 WK LOW / HIGH ( )462.3 1094

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.